Posts

Showing posts with the label Diagnostic

Immuno Oncology Assays Market Surpasses the growth during 2019-2027

Image
  Immuno Oncology Assays Next-generation sequencing applications include immuno-oncology Assays. For real-time measurements or continuous analysis, immuno oncology tests assist to preserve cell shape as well as cell health. T cell assays, Tumor killing assays, Tumor cell assays, Natural killer cell assays, Macrophage assays, and Dendritic cell assays are among the immuno oncology Assays available. Immuno Oncology Assays Market Drivers- During the projected period, new product releases are likely to drive the immuno oncology assays market forward. For example, Roche Diagnostics released the VENTANA HER2 Dual ISH DNA Probe Cocktail test in April 2019 for detecting the biomarker human epidermal growth factor receptor 2 (HER2) in breast and gastric malignancies. In addition, leading market players are focusing on releasing innovative immuno oncology assays, which is projected to propel the immune oncology assays market forward. For example, in August 2018, Thermo Fisher Scientific r

Adenovirus Diagnostic Testing Is Done To Trace Adenovirus, Which Is a Medium-Sized and Non-Developed Category of Virus Containing a Double-Stranded DNA

Image
  Adenovirus Diagnostic Testing is done all over the world, including in regions such as Germany, Japan, and Mexico. Adenovirus diagnostic testing is administered to patients who are diagnosed with adenovirus. Adenoviruses are extremely common in children and they can cause serious illness if not detected and treated in time. Currently, the most widely used adenovirus diagnostic testing types are the use of PCR-based antigen identification tests and polymerase chain reactions (PCR). There are several problems associated with PCR-based tests such as low sensitivity and false-positive results. In addition, PCR amplifies the genetic material within the virus and does not allow for the generation of template clones from non-genetic DNA. The use of an antigen-specific fluorescent marker probe has recently emerged as one of the more effective ways of Adenovirus Diagnostic Testing . These tests require one or more DNA probes to be randomly introduced into the patient's bloodstream. Based

Popular posts from this blog

Security Robot Market is Estimated To Witness High Growth Owing To Increasing Demand for Enhanced Surveillance

The Ever-Evolving Landscape of the Scottish Whisky Market during the Forecast Period 2019-2027

Monochloroacetic Acid (MCAA) Market Is Estimated To Witness High Growth Owing To Increasing Demand for Surfactants and Herbicides